BSG and cancer: The initial characterization of CD147 in cancer cells demonstrated a proportion of CD147 in tumour-conditioned media [14] and subsequent studies have shown that CD147 is released from the cell surface in a full length soluble form [92] or a 22-kDa proteolytic cleavage product not associated with vesicles [93].